FR2981572B1 - Compositions pharmaceutiques d'acide ursodesoxycholique - Google Patents

Compositions pharmaceutiques d'acide ursodesoxycholique Download PDF

Info

Publication number
FR2981572B1
FR2981572B1 FR1250462A FR1250462A FR2981572B1 FR 2981572 B1 FR2981572 B1 FR 2981572B1 FR 1250462 A FR1250462 A FR 1250462A FR 1250462 A FR1250462 A FR 1250462A FR 2981572 B1 FR2981572 B1 FR 2981572B1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
ursodesoxycholic acid
ursodesoxycholic
acid
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1250462A
Other languages
English (en)
Other versions
FR2981572A1 (fr
Inventor
Pukhraj Bothra Chandanmal
N S V Raju
Kandarapu Raghupathi
R Srinivasan
Rao Maram Sambasiva
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INOPHARM Ltd
Original Assignee
INOPHARM Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INOPHARM Ltd filed Critical INOPHARM Ltd
Publication of FR2981572A1 publication Critical patent/FR2981572A1/fr
Application granted granted Critical
Publication of FR2981572B1 publication Critical patent/FR2981572B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
FR1250462A 2011-10-21 2012-01-17 Compositions pharmaceutiques d'acide ursodesoxycholique Active FR2981572B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3612/CHE/2011 2011-10-21
IN3612CH2011 2011-10-21

Publications (2)

Publication Number Publication Date
FR2981572A1 FR2981572A1 (fr) 2013-04-26
FR2981572B1 true FR2981572B1 (fr) 2018-01-19

Family

ID=48048969

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1250462A Active FR2981572B1 (fr) 2011-10-21 2012-01-17 Compositions pharmaceutiques d'acide ursodesoxycholique

Country Status (2)

Country Link
FR (1) FR2981572B1 (fr)
WO (1) WO2013057741A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1392714B1 (fr) 2001-03-12 2005-08-31 Intercept Pharmaceuticals, Inc. Steroides comme agonistes de fxr
WO2015198258A1 (fr) * 2014-06-28 2015-12-30 Shilpa Medicare Limited Comprimé dispersible comprenant de l'acide ursodésoxycholique ou ses sels
WO2021099973A1 (fr) * 2019-11-22 2021-05-27 Shilpa Medicare Limited Compositions injectables d'acide ursodésoxycholique
CN115671073A (zh) * 2021-07-22 2023-02-03 华益泰康药业股份有限公司 一种熊去氧胆酸胶囊及其制备方法
CN113975233B (zh) * 2021-10-22 2023-04-18 北京汇诚益健医药科技有限责任公司 一种肠道内稳定的熊去氧胆酸纳米混悬剂的制备方法
CN114504580B (zh) * 2021-12-28 2024-04-16 湖南醇健制药科技有限公司 一种大批量制备熊去氧胆酸制剂的方法
WO2024043843A1 (fr) * 2022-08-22 2024-02-29 Pharmactive Ilac Sanayi Ve Ticaret A.S. Compositions pharmaceutiques comprenant du cdca en tant que principe actif et excipients pertinents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234697A (en) * 1992-06-22 1993-08-10 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
CN101028274A (zh) * 2006-03-03 2007-09-05 北京奇源益德药物研究所 治疗肝胆疾病的熊去氧胆酸制剂及其制备方法
WO2008062475A2 (fr) * 2006-10-26 2008-05-29 Cadila Healthcare Limited Compositions pharmaceutiques d'ursodiol
MX2009011260A (es) * 2007-04-19 2010-03-08 Disphar Int Bv Composicion de dosis elevada de acido ursodeoxicolico.
CN101836957A (zh) * 2009-03-18 2010-09-22 上海慧德医药科技有限公司 熊去氧胆酸固体分散体、制备方法和固体制剂
CN101606906B (zh) * 2009-07-23 2012-05-30 中国人民解放军第三○二医院 熊去氧胆酸纳米混悬剂及其制备方法

Also Published As

Publication number Publication date
WO2013057741A3 (fr) 2013-06-20
FR2981572A1 (fr) 2013-04-26
WO2013057741A2 (fr) 2013-04-25

Similar Documents

Publication Publication Date Title
SMT201600350B (it) Composizioni farmaceutiche
CO6852076A2 (es) Composiciones farmacéuticas inhalables
HK1255729A1 (zh) 包含針對pcsk9的人抗體的藥物組合物
DK3072510T3 (da) Omega-3-fedtsyreestersammensætninger
DK2632493T3 (da) Lægemiddelindgivelsessammensætninger
BR112014003052A2 (pt) composições farmacêuticas
FR2981572B1 (fr) Compositions pharmaceutiques d'acide ursodesoxycholique
FI20135146L (fi) Farmaseuttiset koostumukset ja hoitomenetelmät
CO6940426A2 (es) Formulaciones farmacéuticas
ZA201401027B (en) Formulations of deoxycholic acid and salts thereof
EP2616059A4 (fr) Compositions pharmaceutiques et nutraceutiques d'acide abscisique
CO6801722A2 (es) Composiciones farmacéuticas
EE201300004A (et) Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks
SMT201600342B (it) Composizioni farmaceutiche topiche comprendenti mometasone furoato
SMT201500005B (it) Composizione framaceutica inalabile
FI20125888A (fi) Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö
FR2993781B1 (fr) Composition d'un sucrose-octasulfate et d'un emollient
FR2977478B1 (fr) Composition cosmetique comprenant un compose d'acide cucurbique et un emulsionnant silicone
BR112012026860A2 (pt) composição farmacêutica sólida para neutralizar ácido estomacal
SMT201600243B (it) Composizioni farmaceutiche comprendenti anakinra senza citrato
IT1397838B1 (it) Composizione per la cura delle piante
EP2928462A4 (fr) Procédés d'administration de compositions comprenant de l'acide docosapentaénoïque
PL3305298T3 (pl) Preparaty kwasu deoksycholowego i jego soli
FR2973378B1 (fr) Derives d'acide hydroxybisphosphonique bifonctionnels
BR112013030365A2 (pt) composições para administração percutânea de princípio ativo fisiologicamente

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLSC Publication of the preliminary search report

Effective date: 20170224

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13